Form of Stock Grant Agreement under the Context Therapeutics Inc. 2021 Long-Term Incentive Plan

The Company hereby grants                      shares of $0.001 par value per share of Common Stock (the “Stock Grant”) of Context Therapeutics Inc. (the “Company”), to                      (the “Grantee”), subject to the terms and provisions of the Context Therapeutics Inc. 2021 Long-Term Performance Incentive Plan (the “Plan”) insofar as the same are applicable to shares of Stock granted thereunder. The terms and provisions of the Plan are incorporated herein by reference.

The Stock Grant is fully vested as of the date hereof.

The Stock Grant is subject to applicable tax withholding. As a condition to receipt of this grant, to the extent such withholding obligations exceed Grantee’s other compensation due from the Company, Grantee agrees to remit to the Company such additional amounts in cash as are necessary to satisfy such required withholding. Any and all withholding obligations may be settled with shares of Stock already owned by Grantee or by the withholding of shares of Stock granted herein, subject to the terms and conditions determined by the Compensation Committee of the Company’s Board of Directors which administers the Plan.

The Company shall deliver to Grantee the applicable number of shares of Common Stock of the Company following Grantee’s satisfaction of all applicable tax withholding obligations and Grantee shall have all rights of a shareholder with respect to such delivered shares.

All notices required to be given hereunder shall be mailed by registered or certified mail to the Company to the attention of its Secretary, at                      and to Grantee at Grantee’s address as it appears on the Company’s books and records unless either of said parties has duly notified the other in writing of a change in address.